Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Full-length human GLP-1 receptor structure without orthosteric ligands
Fan Wu, Linlin Yang, Kaini Hang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 425
GPCR activation mechanisms across classes and macro/microscales
Alexander S. Hauser, Albert J. Kooistra, Christian Munk, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 11, pp. 879-888
Open Access | Times Cited: 189
Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists
Xin Zhang, Matthew J. Belousoff, Peishen Zhao, et al.
Molecular Cell (2020) Vol. 80, Iss. 3, pp. 485-500.e7
Open Access | Times Cited: 172
Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
Fenghui Zhao, Qingtong Zhou, Zhaotong Cong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Mechanisms of adhesion G protein–coupled receptor activation
Alexander Vizurraga, Rashmi Adhikari, Jennifer Yeung, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 41, pp. 14065-14083
Open Access | Times Cited: 136
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 47, pp. 29959-29967
Open Access | Times Cited: 123
Structure and dynamics of the CGRP receptor in apo and peptide-bound forms
Tracy M. Josephs, Matthew J. Belousoff, Yi-Lynn Liang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 73
Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
Zhaotong Cong, Li-Nan Chen, Honglei Ma, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 69
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Sonalika Bhalla, Sidharth Mehan, Andleeb Khan, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 142, pp. 104896-104896
Closed Access | Times Cited: 62
Structural perspective of class B1 GPCR signaling
Zhaotong Cong, Yi-Lynn Liang, Qingtong Zhou, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 4, pp. 321-334
Open Access | Times Cited: 58
Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation
Giuseppe Deganutti, Yi-Lynn Liang, Xin Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 40
Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
N. Hung, Jinan Wang, Yinglong Miao
JACS Au (2023) Vol. 3, Iss. 11, pp. 3165-3180
Open Access | Times Cited: 22
Conformational transitions and activation of the adhesion receptor CD97
Chunyou Mao, Ru-Jia Zhao, Ying-Jun Dong, et al.
Molecular Cell (2024) Vol. 84, Iss. 3, pp. 570-583.e7
Closed Access | Times Cited: 10
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
A combined activation mechanism for the glucagon receptor
Giulio Mattedi, Silvia Acosta‐Gutiérrez, Timothy Clark, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 27, pp. 15414-15422
Open Access | Times Cited: 66
Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Geke Aline Boer, Jens J. Holst
Biology (2020) Vol. 9, Iss. 12, pp. 473-473
Open Access | Times Cited: 65
A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
Wen Sun, Li-Nan Chen, Qingtong Zhou, et al.
Cell Research (2020) Vol. 30, Iss. 12, pp. 1098-1108
Open Access | Times Cited: 55
Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes
Xin Zhang, Matthew J. Belousoff, Yi Liang, et al.
Cell Reports (2021) Vol. 36, Iss. 2, pp. 109374-109374
Open Access | Times Cited: 46
New Insights into the Structure and Function of Class B1 GPCRs
Brian P. Cary, Xin Zhang, Jianjun Cao, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 3, pp. 492-517
Open Access | Times Cited: 35
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
Lijing Wang
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1547-1559
Open Access | Times Cited: 32
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 1-34
Open Access | Times Cited: 28
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wenwei Wan, Qikai Qin, Linshan Xie, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 751-751
Open Access | Times Cited: 21
Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort study from the Global Collaborative Network
Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top